Prediction of Efficacy and Side Effects of Chemotherapy in Colorectal Cancer

作者: Jan Stoehlmacher

DOI: 10.1007/978-3-540-46091-6_8

关键词:

摘要: Treatment of gastrointestinal cancers has significantly advanced over the last several years with introduction effective chemotherapeutic and targeted drugs. Providing individual treatment low toxicity but maximum benefit is still an unsolved problem. Inter-individual variation drug efficacy mainly determined by genetic polymorphisms. The approach pharmacogenetics pharmacogenomics developing as a valuable tool to design tailored therapy. This review focuses on clinically significant polymorphisms in genes involved metabolism chemotherapy used cancer: fluoropyrimidines, irinotecan, platinum. In addition, first results therapy including cetuximab bevacizumab are discussed.

参考文章(38)
Huai-Rong Luo, Xue-Mei Lü, Yong-Gang Yao, Nobuyuki Horie, Keiichi Takeishi, Lynn B. Jorde, Ya-Ping Zhang, Length polymorphism of thymidylate synthase regulatory region in Chinese populations and evolution of the novel alleles. Biochemical Genetics. ,vol. 40, pp. 41- 51 ,(2002) , 10.1023/A:1014589105977
Robert B. Diasio, Glen D. Heggie, Jean-Pierre Sommadossi, David S. Cross, William J. Huster, Clinical Pharmacokinetics of 5-Fluorouracil and Its Metabolites in Plasma, Urine, and Bile Cancer Research. ,vol. 47, pp. 2203- 2206 ,(1987)
T Takayama, Y Niitsu, S Sakamaki, Y Takahashi, T Katahira, N Ban, T Kura, Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Research. ,vol. 56, pp. 3577- 3582 ,(1996)
C G Leichman, H J Lenz, L Leichman, K Danenberg, J Baranda, S Groshen, W Boswell, R Metzger, M Tan, P V Danenberg, Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. Journal of Clinical Oncology. ,vol. 15, pp. 3223- 3229 ,(1997) , 10.1200/JCO.1997.15.10.3223
L Zoetekouw, H R Waterham, D J Richel, A B van Kuilenburg, F Baas, J Haasjes, R Meinsma, A H van Gennip, E W Muller, Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency. Clinical Cancer Research. ,vol. 7, pp. 1149- 1153 ,(2001)
Mark J. Ratain, Lalitha Iyer, Federico Innocenti, Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug Metabolism and Disposition. ,vol. 29, pp. 596- 600 ,(2001)
Nobuyuki Horie, Hideo Aiba, Katsuhiko Oguro, Hiroatsu Hojo, Keiichi Takeishi, Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase Cell Structure and Function. ,vol. 20, pp. 191- 197 ,(1995) , 10.1247/CSF.20.191
S T Pullarkat, J Stoehlmacher, V Ghaderi, Y-P Xiong, S A Ingles, A Sherrod, R Warren, D Tsao-Wei, S Groshen, H-J Lenz, Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics Journal. ,vol. 1, pp. 65- 70 ,(2001) , 10.1038/SJ.TPJ.6500012
Sanjay K. Srivastava, Sharad S. Singhal, Xun Hu, Yogesh C. Awasthi, Piotr Zimniak, Shivendra V. Singh, Differential Catalytic Efficiency of Allelic Variants of Human GlutathioneS-Transferase Pi in Catalyzing the Glutathione Conjugation of Thiotepa Archives of Biochemistry and Biophysics. ,vol. 366, pp. 89- 94 ,(1999) , 10.1006/ABBI.1999.1217